The future of small molecule development is being redefined. But with innovation comes complexity including formulation challenges, developability roadblocks, tight timelines and limited resources. For early-stage pharma companies, the stakes are high; missteps can lead to costly delays, regulatory setbacks, and missed market opportunities.
Discover strategies with the industry experts as we break down the critical phases of small molecule development, covering formulation strategies, manufacturing solutions, and CMC best practices to accelerate your path to the clinic. Beyond the science, we’ll tackle the drug development business, including aligning with investor expectations and securing funding in a competitive landscape.
Join us in London to gain the insights, tools, and connections you need to de-risk development, optimize your strategy, and fast-track your innovation to market success. Plus, take advantage of exclusive 1:1 office hour with our experts to discuss your molecule challenges.
Who Should Attend
Ideal for emerging pharma startups seeking to accelerate clinical entry and deliver innovative medicines to patients faster. Suited for professionals in Preclinical & Formulation Development, CMC, Drug Substance & Product Development, Project Management, Manufacturing & Operations, Supply Chain Management, as well as pharma consultants seeking a CDMO partner for developing and manufacturing oral solid dosage forms.
Agenda:
|
TIME |
AGENDA |
SPEAKERS |
|
10:00 am – 10:45 am |
Breakfast & Registration |
|
|
10:45 am – 11:00 am |
Welcome Note |
Matthew Streeter General Manager, Catalent Nottingham
Matt Ling (moderator) Director, Scientific Services, Catalent Nottingham |
|
11:00 am – 11:30 am |
Formulating in Early Discovery: Embedding Formulation Considerations into Hit-To-Lead Optimization |
David Pearson Director of Form and Formulation, Sygnature Discovery |
|
11:30 am – 12:00 pm |
Formulating with Less API: Application of API Sparing Techniques in Oral Drug Development |
Karl Box Chief Scientific Officer, Pion Inc |
|
12:00 pm – 1:00 pm |
Power Lunch |
|
|
1:00 pm – 1:30 pm |
Formulating for Success: Early-Phase Strategies to Avoid Costly Setbacks |
Stephen Tindal Director, Scientific Advisory, Europe, Catalent |
|
1:30 pm – 2:00 pm |
Manufacturing Insight: Lessons from 12 Years of the Manufacturing Classification System |
Kendal Pitt Visiting Professor, University of Strathclyde & Honorary Professor, Leicester School of Pharmacy, De Montfort University |
|
2:00 pm – 2:30 pm |
Refresh & Recharge |
|
|
2:30 pm – 3:00 pm |
Fast-Tracking Clinical Development: Navigating UK Clinical Trial Regulations to Reduce Risk and Accelerate Timelines |
Karen Chalk Head of Clinical Project Management & Regulatory Affairs, HMR
Sally Dowen Director, Lealto Consulting |
|
3:00 pm – 3:30 pm |
Founder's Insight: Tackling Early Drug Development Challenges with Strategic Partners That Deliver |
Emilia Neuwirt Co-Founder, CEO EMUNO Therapeutics |
|
3:30 pm – 4:15 pm |
Panel Discussion: Securing Capital in a Competitive Market - What Early-Stage Pharma Needs to Know |
Ronak Savla Director, Strategic Ventures, Catalent
Graham Mills Principal, Abingworth
Owen Smith Partner, 4BIO Capital
Angelos Georgakis Executive Coach to Biotech Leaders
Jack O’Meara CEO of Helicon
|
|
4:15 pm – 5:00 pm |
Closing & Networking Cocktail |
Sherief Shaaban VP and Chief Commercial Officer, Catalent |
ABOUT CATALENT NOTTINGHAM
Catalent’s Nottingham facility focuses on early-stage development of small molecule drug candidates from the bench to clinic. This facility offers an array of services that support oral dosage forms that include characterization, formulation and analytical development, manufacturing and clinical packaging, labelling and worldwide distribution. Our Nottingham location is the home of our bioavailability enhancement technologies, including Catalent Spray Drying and Hot Melt Extrusion to support the needs of our client’s most challenging compounds. This MHRA approved facility includes cGMP dose form manufacturing, packaging, analytical and development laboratories with OEB 1-3 and controlled drug storage to handle even your most challenging products
Registration: Free to attend, please sign up via this link.
Contact
Accelerate Small Molecule Development with Smart Formulation & Funding Strategies
Wednesday 4 June 2025, 10.00 - 17.00
4 June 2025 10:00
Royal Society of Chemistry
Burlington House
Piccadilly
London, London W1J 0BA
United Kingdom
Burlington House
Piccadilly
London, London W1J 0BA
United Kingdom